BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Ohno M, Nishida A, Otsuki A, Yokota Y, Imai T, Bamba S, Inatomi O. Leucine-rich alpha-2 glycoprotein as a superior biomarker to C-reactive protein for detecting small bowel lesions in Crohn’s disease. World J Gastrointest Endosc 2025; 17(2): 100793 [PMID: 39989852 DOI: 10.4253/wjge.v17.i2.100793]
URL: https://www.wjgnet.com/1948-5190/full/v17/i2/100793.htm
Number Citing Articles
1
Arunkumar Krishnan. Leucine-rich alpha-2 glycoprotein for detecting small bowel lesions in Crohn’s disease: A critical review and the path forwardWorld Journal of Gastrointestinal Endoscopy 2025; 17(4): 106671 doi: 10.4253/wjge.v17.i4.106671
2
Iyad A Issa, Taly Issa. Assessing endoscopic remission in small bowel Crohn's disease: Are markers enough?World Journal of Gastrointestinal Endoscopy 2025; 17(4): 106083 doi: 10.4253/wjge.v17.i4.106083
3
Ali Morshed, Foroogh Alborzi Avanaki, Arash Miroliaee, Alireza Azarboo, Amirhossein Ghaseminejad-Raeini, Amirhossein Shirinezhad, Sina Khayatian, Melika Latifinasab, Najmeh Aletaha, Nasser Ebrahimi Daryani. C-reactive protein/albumin ratio as a potential inflammatory marker for predicting clinical outcomes in patients with moderate to severe ulcerative colitis: A retrospective studyMedicine 2026; 105(30) doi: 10.1097/MD.0000000000049909